The Healthcare Leadership Council (HLC) was at it again driving collaborative, patient-focused initiatives to improve patient care. Last month, Sanofi joined the HLC at “Innovations in Diabetes Therapies and Care,” a Capitol Hill briefing aimed to increase the understanding of diabetes and to discuss ways to help improve its management. As a leader in diabetes […]VIEW FULL POST
In recognition of National Men’s Health Week, we asked Robert Marotta, Michael Siemers and Cary Yonce, colleagues from our Winthrop group, a business of Sanofi US, to share tips on how they make health a priority
We’re in the midst of National Men’s Health Week—a time to recognize and encourage men to take care of their […]
This post was authored by Cary Yonce, Vice President, General Therapeutics and Life-Cycle Management at Sanofi US.
The life-cycle of a medicine begins in the laboratory and ends long after its patent expires. At Sanofi, we follow an approach known as “life-cycle management” (LCM) to optimize medicines and treatments throughout their development. LCM is used in […]
This post was authored by Jez Moulding, President, North America Pharmaceuticals
Last weekend, I attended the 75th American Diabetes Association (ADA) Scientific Sessions in Boston. For the diabetes community, ADA is one of the most highly anticipated events of the year. I was joined by more than 18,000 attendees who saw first-hand the difference Sanofi is making by providing […]